Coronavirus Response Debate
Full Debate: Read Full DebateKerry McCarthy
Main Page: Kerry McCarthy (Labour - Bristol East)Department Debates - View all Kerry McCarthy's debates with the Department of Health and Social Care
(4 years, 5 months ago)
Commons ChamberYes, I agree strongly with my hon. Friend, who makes the point very clearly. No matter the level of new infections in any area, having better and better data helps us give more support to those who have coronavirus. Whether it is an outbreak with large numbers, as we saw for instance in Leicester and some other cities, where there is clear concerted action with support from national Government to go in and root it out, or whether it is an area with very low levels of background infections, like her own, where the local authority having the data will allow it to support the few positive cases, better data will help the co-ordination of the national and local response. We have said all along that tackling the virus is best done by the national level and local level working together, and I am really pleased that we are able to get this increased data out to increase that co-ordination still further.
I want to thank the Health Secretary for two things while I have the chance: the deal on Kaftrio for cystic fibrosis patients, which is so important to so many of them; and for meeting my constituent, Jake Ogborne, recently to talk about access to the drug Spinraza—I hope we have some news on that soon. However, for people with such conditions who have been shielding for the last few months, there is still a great deal of uncertainty, concern and confusion about whether it is safe for them to go outside and about what they can actually do, especially when other people are breaking social distancing, not wearing masks and so on. What reassurance can he give that people will be safe if they tentatively put a foot outside?
I pay tribute to the hon. Lady’s campaigning on these issues. We have worked closely together to bring really positive news on the treatments for cystic fibrosis on which she has campaigned so strongly. She also made the case very clearly on Spinraza, which I have since discussed with NHS England. It is, of course, NHS England’s statutory responsibility to take a decision, but I discussed it with NHS England, as I committed to do so to her and her constituent, Jake.
I say to all those in the shielding category that we have recommended that shielding restrictions come to an end at the end of this month because it is clinically advised that the levels of new infections are low enough that it is safe to do so. It is safe to do so. I plead with those who are shielding to listen to this clinical advice, because we also know that staying at home and not seeing other people has downsides to health too. If anyone wants proof that we will not take this step unless we are confident that it is safe, we have paused the end of shielding in Leicester exactly because rates of infection are higher—to keep people safe. People can be assured that it is safe, from the end of this month, for those in the shielding category to go out into the community, taking the precautions that everybody should take.